In a patient with adrenal insufficiency who has orthostatic hypotension and tachycardia, should they be given fludrocortisone, increased hydrocortisone (Solu‑Cortef), or adjust their antihypertensive medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

This patient should take fludrocortisone, not increase Solu-Cortef or adjust antihypertensives.

The blood pressure readings demonstrate classic orthostatic hypotension (standing BP 118/80 with HR 92 vs sitting/lying BP 141/81-79 with HR 66-73), indicating mineralocorticoid deficiency that requires fludrocortisone adjustment.

Clinical Reasoning

The orthostatic pattern is diagnostic:

  • Standing BP drops by 23 mmHg systolic (141→118)
  • Heart rate increases by 19-26 bpm when standing (compensatory tachycardia)
  • This represents inadequate mineralocorticoid replacement, not glucocorticoid deficiency

Why fludrocortisone is the answer:

According to French consensus guidelines, monitoring and adjustment of mineralocorticoid replacement should be based on clinical signs of under-dosage including hypotension 1. The FDA label confirms fludrocortisone dosing ranges from 0.1-0.2 mg daily for primary adrenal insufficiency, with dose adjustments for transient hypotension 2.

The guidelines explicitly state that patients with primary adrenal insufficiency require mineralocorticoid replacement using fludrocortisone at a mean dose of 100 mcg/day (individually adjusted) 1. Clinical monitoring should identify signs of under-dosage such as hypotension 1.

Why NOT increase hydrocortisone:

The sitting/lying blood pressures are actually elevated (141/81-79), suggesting adequate or even excessive glucocorticoid replacement. Increasing hydrocortisone would worsen hypertension and is only indicated for acute illness, stress, or adrenal crisis 1. The patient shows no signs of acute adrenal insufficiency requiring stress-dose steroids.

Why NOT adjust antihypertensives:

This is not essential hypertension—it's positional hypotension from mineralocorticoid deficiency. The elevated sitting/lying pressures may actually reflect compensatory mechanisms for chronic volume depletion. Guidelines state that in hypertensive PAI patients, fludrocortisone dose reduction should be considered, but essential hypertension should be treated by adding vasodilators, not stopping mineralocorticoid replacement 3, 4. However, this patient's primary problem is orthostatic hypotension, not hypertension.

Management Algorithm:

  1. Increase fludrocortisone dose (typically from 0.1 mg to 0.15-0.2 mg daily) 2

  2. Ensure adequate salt intake (guidelines recommend free dietary sodium intake) 1

  3. Monitor response with:

    • Orthostatic vital signs (target: <20 mmHg systolic drop)
    • Electrolytes (watch for hypokalemia with higher doses)
    • Plasma renin activity (aim for upper normal range) 4, 5
    • Salt craving, postural dizziness symptoms 4
  4. Reassess in 1-2 weeks and titrate fludrocortisone accordingly

Critical Pitfalls to Avoid:

  • Don't mistake orthostatic hypotension for inadequate glucocorticoid replacement—the compensatory tachycardia and positional nature point to volume/mineralocorticoid issues
  • Don't stop or reduce fludrocortisone because of elevated sitting BP—the orthostatic drop indicates under-replacement 3
  • Don't use stress-dose hydrocortisone for chronic orthostatic symptoms—this is for acute illness only 1
  • Glucocorticoid-induced adrenal insufficiency patients should NOT receive fludrocortisone 6, but this patient has primary adrenal insufficiency requiring both replacements

The evidence strongly supports that fludrocortisone under-replacement is common in clinical practice 7, and symptoms like postural dizziness persist in many treated PAI patients, suggesting chronic mineralocorticoid under-replacement is widespread.

Related Questions

What is the recommended monitoring plan for a patient with adrenal insufficiency receiving glucocorticoid and mineralocorticoid replacement?
How should adrenal insufficiency be treated, including glucocorticoid and mineralocorticoid replacement, acute crisis management, stress dosing, and follow‑up monitoring?
Can mirtazapine be prescribed to a patient with adrenal insufficiency who is receiving stable glucocorticoid replacement therapy?
What are the recommended intravenous doses of Solu‑Cortef (hydrocortisone) for a patient with Addison’s disease for routine maintenance and during an adrenal crisis?
Is adrenal insufficiency likely after a 5‑day course of systemic glucocorticoids, and is a taper or stress‑dose steroids required?
What causes the sensation of the rectum collapsing against the vaginal wall?
What is the maximum recommended adult dose of diphenhydramine?
What is the recommended protocol for switching a patient taking bupropion 300 mg daily to sertraline?
I have a patient from the Philippines with a positive QuantiFERON test who reports receiving one pill daily for six months in [DATE] but cannot recall the medication name; was latent tuberculosis infection (LTBI) ever treated with a single‑pill daily regimen at that time?
Should a 45-year-old patient with no family history of colorectal cancer and only hemorrhoids undergo a screening colonoscopy now?
What is the recommended treatment for a patient with a Patient Health Questionnaire‑9 (PHQ‑9) score of 13 and a Generalized Anxiety Disorder‑7 (GAD‑7) score of 12?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.